We are live on ! Find out more
VANI icon

Vivani Medical

33 hedge funds and large institutions have $4.29M invested in Vivani Medical in 2023 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 11 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

12% more capital invested

Capital invested by funds: $3.83M → $4.29M (+$453K)

0.45% less ownership

Funds ownership: 8.89%8.45% (-0.45%)

3% less funds holding

Funds holding: 3433 (-1)

20% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 5

64% less repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 11

Holders
33
Holders Change
-1
Holders Change %
-2.94%
% of All Funds
0.53%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
4
Increased
4
Reduced
11
Closed
5
Calls
$1K
Puts
Net Calls
+$1K
Net Calls Change
-$25K

VANI Hedge Fund Activity: Q1 2023 in Review

33 of the 6,283 institutional investors tracked by Wall St. Rank reported a position in Vivani Medical (VANI) for Q1 2023, worth a combined $4.29M — up 12% from $3.83M a quarter earlier.

Sellers outnumbered buyers: 5 funds closed out of VANI and 4 opened new positions — a net loss of 1 holder — while 11 trimmed existing stakes and 4 added.

The largest buyer was Vanguard Group, adding an estimated $114K. The largest seller was Tanager Wealth Management, cutting an estimated $272K.

  • 33 institutional investors held Vivani Medical (VANI) as of Q1 2023, down from 34 in Q4 2022.
  • Funds reported $4.29M of Vivani Medical stock for Q1 2023, up 12% quarter-over-quarter.
  • 4 funds opened new Vivani Medical positions in Q1 2023 and 5 closed out, a net change of -1 holder.
  • The largest Vivani Medical buyer in Q1 2023 was Vanguard Group, an estimated $114K added.
  • The largest Vivani Medical seller in Q1 2023 was Tanager Wealth Management, an estimated $272K sold.

Based on aggregated 13F filings for Q1 2023.